There is considerable interest in being able to clearly identify vulnerable plaque (VP) and research efforts are intensifying. Several invasive imaging technologies claim to detect VP, and while the link between VP identification, plaque rupture and clinical events has yet to be firmly established, progress is being made in the research.
October 30, 2008 - Thoratec Corp. this week notified healthcare professionals of a worldwide correction of the HeartMate ...
There is skepticism among cardiologists whether flat panel detectors can help lower the X-ray dose more than using traditional image intensifiers in the cath lab. There was a story concerning this in the last issue of DAIC which said flat panel detectors are replacing image intensifiers partly because they help lower the X-ray exposure to patients.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 29, 2008 - Nearly 18 months of data from Cappella’s Sideguard I and II self-expanding side branch heart stent in ...
October 30, 2008 - Abbott this week received a 2008 Chicago Innovation Award for its XIENCE V Everolimus Eluting ...
There have been numerous new products released in the past year to enhance implantable pacing and defibrillation devices, but new advances in remote monitoring seem to be paving the way of the future.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 30, 2008 - CHF Solutions said seven studies supporting ultrafiltration therapy’s effectiveness and benefits in ...
October 30, 2008 - Thinking Systems is debuting at RSNA 2008 its new release of the company’s unified Web-based ThinkingPACS/ThinkingRIS with comprehensive solutions for radiology, cardiology and molecular imaging.
October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent Graft with an optimized delivery system.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Covidien's Optistar Elite contrast delivery system injects contrast media-related drugs into a patient’s vascular system to aid in obtaining diagnostic images when used with magnetic resonance (MR) imaging equipment.
October 29, 2008 - Critical Diagnostics today announced the publication of a research paper and an accompanying ...
Oxilan (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity. Its reported low viscosity allows it to reach distal vessels. It also has the lowest osmolality of all nonionic monomers in the U.S. Together, these properties facilitate ease of injection, help improve patient comfort and provide visualization and image quality.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
OASIS 1.2T MRI is designed to deliver high performance and patient comfort. The Oasis open architecture, High-Field strength, Zenith RF technology and fast gradients drive diagnostic confidence and image quality.
October 28, 2008 – Thermedical said yesterday it received a $3.6 million competing phase two renewal grant from the ...
October 29, 2008 - To offer hospitals more versatility and a seamless transition from endovascular imaging to surgical intervention on a single system, Toshiba America Medical Systems Inc. is partnering with surgical table manufacturer MAQUET to provide new solutions for Toshiba’s Infinix-i product line.